Range Cancer Therapeutics Index
(CNCR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CNCR | ||||
| Company | Range Cancer Therapeutics Index | ||||
| Price Information | |||||
| Exchange | NASDAQ | ||||
| Open | 9.41 | ||||
| High | 9.41 | ||||
| Low | 9.02 | ||||
| Latest | 9.02 | ||||
| Change | +0.14 | ||||
| % Change | +1.58% | ||||
| Volume | 3,000 | ||||
| 20-Day Average Volume | 2,235 | ||||
| Previous Close | 8.88 | ||||
| Industry | N/A | ||||
| Has Options | No | ||||
| Technicals | |||||
| 20-Day Moving Average | 9.18 | ||||
| 20-Day Raw Stochastic | 21.47% | ||||
| 20-Day Relative Strength | 45.16 | ||||
| Weighted Alpha | -42.25 | ||||
| Today's Opinion | 100% Sell | ||||
| Previous Opinion | 100% Sell | ||||
| Last Month's Opinion | 80% Sell | ||||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.12% since 05/19/25 | ||||
| Low | 8.87 on 05/23/25 | ||||
| High | 9.41 on 05/27/25 | ||||
| 1-Month | |||||
| %Chg | -7.72% since 04/25/25 | ||||
| Low | 8.67 on 05/14/25 | ||||
| High | 10.30 on 05/02/25 | ||||
| 3-Month | |||||
| %Chg | -19.94% since 02/27/25 | ||||
| Low | 7.88 on 04/07/25 | ||||
| High | 11.48 on 03/03/25 | ||||
| 6-Month | |||||
| %Chg | -36.41% since 11/27/24 | ||||
| Low | 7.88 on 04/07/25 | ||||
| High | 14.55 on 12/09/24 | ||||
| Key Statistics | |||||
| Market Capitalization, $K | 7,036 | ||||
| Shares Outstanding, K | 780 | ||||
| Annual Sales | 0 | ||||
| Annual Net Income | 0 | ||||
| Last Quarter Sales | N/A | ||||
| Last Quarter Net Income | N/A | ||||
| 60-Month Beta | 0.90 | ||||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | ||||
| Latest Earnings Date | N/A | ||||
| Most Recent Dividend | N/A | ||||
| Next Ex-Dividends Date | 12/29/21 | ||||
| Ratios | |||||
| Price/Earnings ttm | N/A | ||||